Literature DB >> 18499606

The effects of aromatic anesthetics on dorsal horn neuronal responses to noxious stimulation.

Aubrey Yao1, JongBun Kim, Richard Atherley, Steven L Jinks, Earl Carstens, Sean Shargh, Alana Sulger, Joseph F Antognini.   

Abstract

BACKGROUND: Gamma-aminobutyric acid type A receptor potentiation and/or N-methyl-d-aspartate (NMDA) receptor inhibition might explain the anesthetic properties of fluorinated aromatic compounds. We hypothesized that depression of dorsal horn neuronal responses to noxious stimulation would correlate with the magnitude of effect of benzene (BNZ), o-difluorobenzene, and hexafluorobenzene (HFB) on NMDA receptors.
METHODS: Rats were anesthetized with desflurane. A T13-L1 laminectomy allowed extracellular recording of neuronal activity from the lumbar spinal cord. After discontinuing desflurane administration, MAC for each aromatic anesthetic was determined. A 5-s noxious mechanical stimulus was then applied to the hindpaw receptive field of nociceptive dorsal horn neurons, and single-neuron responses were recorded at 0.8 and 1.2 MAC. These responses were also recorded in decerebrate rats receiving BNZ and HFB at 0-1.2 MAC.
RESULTS: In intact rats, depression of responses of dorsal horn neurons to noxious stimulation by peri-MAC increases in BZN, o-difluorobenzene, and HFB correlated directly with their in vitro capacity to block NMDA receptors. In decerebrate rats, 1.2 MAC BNZ depressed nociceptive responses by 60%, with a further percentage decrease continuing from 0.8 to 1.2 MAC approximately equal to that found in intact rats. In decerebrate rats, HFB caused a progressive dose-related decrease in MAC (maximum 25%), but in intact rats, an increase from 0.8 to 1.2 neuronal response caused an (insignificant) increase in neuronal response.
CONCLUSIONS: The findings in intact rats suggest that NMDA blockade contributes to the depression of dorsal horn neurons to nociceptive stimulation by fluorinated aromatic anesthetics. These results, combined with the additional findings in decerebrate rats, suggest that supraspinal effects (perhaps on gamma-aminobutyric acid type A receptors) may have a supraspinal facilitatory effect on nociception for HFB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18499606      PMCID: PMC2670468          DOI: 10.1213/ane.0b013e3181732ee3

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  21 in total

1.  General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit.

Authors:  Rachel Jurd; Margarete Arras; Sachar Lambert; Berthold Drexler; Roberta Siegwart; Florence Crestani; Michael Zaugg; Kaspar E Vogt; Birgit Ledermann; Bernd Antkowiak; Uwe Rudolph
Journal:  FASEB J       Date:  2002-12-03       Impact factor: 5.191

2.  Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics.

Authors:  M W Hollmann; H T Liu; C W Hoenemann; W H Liu; M E Durieux
Journal:  Anesth Analg       Date:  2001-05       Impact factor: 5.108

3.  Effect of isoflurane and other potent inhaled anesthetics on minimum alveolar concentration, learning, and the righting reflex in mice engineered to express alpha1 gamma-aminobutyric acid type A receptors unresponsive to isoflurane.

Authors:  James M Sonner; David F Werner; Frank P Elsen; Yilei Xing; Mark Liao; R Adron Harris; Neil L Harrison; Michael S Fanselow; Edmond I Eger; Gregg E Homanics
Journal:  Anesthesiology       Date:  2007-01       Impact factor: 7.892

4.  Anesthetic and convulsant properties of aromatic compounds and cycloalkanes: implications for mechanisms of narcosis.

Authors:  Z Fang; J Sonner; M J Laster; P Ionescu; L Kandel; D D Koblin; E I Eger; M J Halsey
Journal:  Anesth Analg       Date:  1996-11       Impact factor: 5.108

5.  Isoflurane and nociception: spinal alpha2A adrenoceptors mediate antinociception while supraspinal alpha1 adrenoceptors mediate pronociception.

Authors:  Wade S Kingery; Geeta S Agashe; Tian Z Guo; Shigehito Sawamura; M Frances Davies; J David Clark; Brian K Kobilka; Mervyn Maze
Journal:  Anesthesiology       Date:  2002-02       Impact factor: 7.892

6.  GABA(A) receptor blockade antagonizes the immobilizing action of propofol but not ketamine or isoflurane in a dose-related manner.

Authors:  James M Sonner; Yi Zhang; Caroline Stabernack; Wella Abaigar; Yilei Xing; Michael J Laster
Journal:  Anesth Analg       Date:  2003-03       Impact factor: 5.108

7.  Beta3-containing gamma-aminobutyric acidA receptors are not major targets for the amnesic and immobilizing actions of isoflurane.

Authors:  Mark Liao; James M Sonner; Rachel Jurd; Uwe Rudolph; Cecilia M Borghese; R Adron Harris; Michael J Laster; Edmond I Eger
Journal:  Anesth Analg       Date:  2005-08       Impact factor: 5.108

8.  The effect of N-methyl-D-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo-controlled experimental human study.

Authors:  L Arendt-Nielsen; S Petersen-Felix; M Fischer; P Bak; P Bjerring; A M Zbinden
Journal:  Anesth Analg       Date:  1995-07       Impact factor: 5.108

9.  Anesthetic potency (MAC) is independent of forebrain structures in the rat.

Authors:  I J Rampil; P Mason; H Singh
Journal:  Anesthesiology       Date:  1993-04       Impact factor: 7.892

10.  Does the brain influence somatic responses to noxious stimuli during isoflurane anesthesia?

Authors:  M Borges; J F Antognini
Journal:  Anesthesiology       Date:  1994-12       Impact factor: 7.892

View more
  1 in total

1.  Propofol produces immobility via action in the ventral horn of the spinal cord by a GABAergic mechanism.

Authors:  Gudrun Kungys; Jongbun Kim; Steven L Jinks; Richard J Atherley; Joseph F Antognini
Journal:  Anesth Analg       Date:  2009-05       Impact factor: 5.108

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.